EUVIMEDEUVIMED entdecken
Crossref

Expression and Role of PDK4 on Childhood Dyslipidemia and Lipid Metabolism in Hyperlipidemic Mice

Wenjuan Cai, Xin Wang, Qian Deng, Jian Gao, Yuqing Chen

Hormone and Metabolic Research · 01.02.2024 · 56 (02) · 167-176

DOI: 10.1055/a-2217-9385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.02.2024. Verfasst von Wenjuan Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology and Metabolic Disease, Anhui Provincial Children's Hospital, Hefei, China. Hauptthemen laut MEDLINE: Pediatric Obesity, MicroRNAs, Hyperlipidemias, Dyslipidemias. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperlipidemia is a common metabolic disorder that can lead to cardiovascular disease. PDK4 is a key enzyme that regulates glucose and fatty acid metabolism and homeostasis. The aim of this study is to explore the correlation between PDK4 expression and dyslipidemia in obese children, and to find new therapeutic targets for hyperlipidemia in children. The expression of PDK4 in serum was detected by qRT-PCR. Receiver operating characteristic curve was used to analyze the relationship between PDK4 and dyslipidemia. Upstream miRNAs of PDK4 were predicted by the database and verified by dual luciferase reporter gene assay and detected by qRT-PCR. The hyperlipidemia mouse model was established by high-fat diet (HFD) feeding, and the metabolic disorders of mice were detected. PDK4 is poorly expressed in the serum of obese children. The upstream of PDK4 may be inhibited by miR-107, miR-27a-3p, and miR-106b-5p, which are highly expressed in the serum of obese children. Overexpression of PDK4 improves lipid metabolism in HFD mice. miR-27a-3p silencing upregulates PDK4 to improve lipid metabolism. In conclusion, PDK4 has a diagnostic effect on dyslipidemia in children, while lipid metabolism in hyperlipidemic mice could be mitigated by upregulation of PDK4, which was inhibited by miR-107, miR-27a-3p and miR-106b-5p on upstream.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pediatric ObesityMicroRNAsHyperlipidemiasDyslipidemiasHumansChildMiceAnimalsLipid Metabolism

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology and Metabolic Disease, Anhui Provincial Children's Hospital, Hefei, China.

Zitieren

APA

Cai, W., Wang, X., Deng, Q., Gao, J., & Chen, Y. (2024). Expression and Role of PDK4 on Childhood Dyslipidemia and Lipid Metabolism in Hyperlipidemic Mice. Hormone and Metabolic Research, 56(02), 167-176. https://doi.org/10.1055/a-2217-9385

Vancouver

Cai W, Wang X, Deng Q, Gao J, Chen Y. Expression and Role of PDK4 on Childhood Dyslipidemia and Lipid Metabolism in Hyperlipidemic Mice. Hormone and Metabolic Research. 2024;56(02):167-176. doi:10.1055/a-2217-9385

BibTeX
@article{Cai2024,
  author = {Cai, Wenjuan and Wang, Xin and Deng, Qian and Gao, Jian and Chen, Yuqing},
  title = {Expression and Role of PDK4 on Childhood Dyslipidemia and Lipid Metabolism in Hyperlipidemic Mice},
  journal = {Hormone and Metabolic Research},
  year = {2024},
  volume = {56},
  number = {02},
  pages = {167--176},
  doi = {10.1055/a-2217-9385}
}
Kostenlos starten →